CORONA Remedies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nirav Mehta, Managing Director and CEO and Promoter of CORONA Remedies Limited, has submitted a declaration confirming that neither he nor any Persons Acting in Concert (PAC) have created any encumbrance (pledge) on the equity shares held by them during financial year 2025-2026. The filing lists 23 entities under the Promoter and Promoter Group category, including family members and two LLPs (NKM Nextgen LLP and KL Next Enterprise LLP). This is a nil/negative disclosure filed with both BSE and NSE.
Positive signal for investors — the absence of any share pledges reduces risk of forced selling pressure and indicates the promoter group has not leveraged their holdings, which is generally viewed favourably for stock stability.